Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health agencies.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as scheduled, the agency’s acting director told staff scientists in an email Monday.

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the Department of Health and Human Services (HHS), the National Institutes of Health (NIH) is clarifying the extent of the freeze’s effect.

The Trump administration continues its deluge of executive orders that directly affect science and research, just days after being sworn in. Following the executive orders (EOs) taking the United States out of the Paris Agreement and World Health Organization and the scientific nonsense in the EO on trans and non-binary people,

New rules include a hold on the review panels the National Institutes of Health uses to evaluate and approve research grants.

An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded. Scientists worry about disruptions to critical research.

The halt has frozen research grants, meetings and key health updates. “Everything is basically in chaos,” said one cancer researcher.

The Trump administration’s freeze on communications from U.S. health agencies is leading to another disruption: the abrupt cancellation of scientific meetings. The move covers a swath of health conditions,

More of President Donald Trump's picks for his cabinet are expected to be confirmed by the U.S. Senate in the coming days after the Republican-controlled chamber began approving them last week. Hearings for other nominees are scheduled for this week as well,